SINTX TECHNOLOGIES, INC EBIT Margin 2012-2025 | SINT
Current and historical EBIT (Earnings Before Interest & Taxes) margin for SINTX TECHNOLOGIES, INC (SINT) over the last 10 years. The current EBIT profit margin for SINTX TECHNOLOGIES, INC as of March 31, 2025 is .
| SINTX TECHNOLOGIES, INC EBIT Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM EBIT | EBIT Margin |
| 2025-03-31 | $0.00B | $-0.01B | -433.33% |
| 2024-12-31 | $0.00B | $-0.01B | -350.00% |
| 2024-09-30 | $0.00B | $-0.02B | -375.00% |
| 2024-06-30 | $0.00B | $-0.01B | -325.00% |
| 2024-03-31 | $0.00B | $-0.01B | -325.00% |
| 2023-12-31 | $0.00B | $-0.01B | -350.00% |
| 2023-09-30 | $0.00B | $-0.01B | -350.00% |
| 2023-06-30 | $0.00B | $-0.01B | -433.33% |
| 2023-03-31 | $0.00B | $-0.01B | -650.00% |
| 2022-12-31 | $0.00B | $-0.01B | -1200.00% |
| 2022-09-30 | $0.00B | $-0.01B | 0.00% |
| 2022-06-30 | $0.00B | $-0.01B | 0.00% |
| 2022-03-31 | $0.00B | $-0.01B | 0.00% |
| 2021-12-31 | $0.00B | $-0.01B | 0.00% |
| 2021-09-30 | $0.00B | $-0.01B | 0.00% |
| 2021-06-30 | $0.00B | $-0.01B | 0.00% |
| 2021-03-31 | $0.00B | $-0.01B | 0.00% |
| 2020-12-31 | $0.00B | $-0.01B | 0.00% |
| 2020-09-30 | $0.00B | $-0.01B | 0.00% |
| 2020-06-30 | $0.00B | $-0.01B | 0.00% |
| 2020-03-31 | $0.00B | $-0.01B | 0.00% |
| 2019-12-31 | $0.00B | $-0.01B | 0.00% |
| 2017-06-30 | $0.01B | $-0.01B | -76.92% |
| 2017-03-31 | $0.01B | $-0.01B | -78.57% |
| 2016-12-31 | $0.02B | $-0.01B | -73.33% |
| 2016-09-30 | $0.02B | $-0.01B | -68.75% |
| 2016-06-30 | $0.02B | $-0.01B | -61.11% |
| 2016-03-31 | $0.02B | $-0.01B | -57.89% |
| 2015-12-31 | $0.02B | $-0.01B | -65.00% |
| 2015-09-30 | $0.02B | $-0.01B | -70.00% |
| 2015-06-30 | $0.02B | $-0.02B | -80.95% |
| 2015-03-31 | $0.02B | $-0.03B | -113.64% |
| 2014-12-31 | $0.02B | $-0.03B | -108.70% |
| 2014-09-30 | $0.02B | $-0.02B | -100.00% |
| 2014-06-30 | $0.02B | $-0.02B | -86.96% |
| 2014-03-31 | $0.02B | $-0.01B | -52.17% |
| 2013-12-31 | $0.02B | $-0.01B | -50.00% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $0.008B | $0.003B |
| SINTX Technologies Inc. is a biomaterials and OEM company. It develops and commercializes silicon nitride for biomedical applications including the spine, dental, oral maxillofacial, podiatry and arthroplasty markets. SINTX Technologies Inc., formerly known as Amedica Corporation, is based in UT, United States. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $183.063B | 22.15 |
| Intuitive Surgical (ISRG) | United States | $172.911B | 71.67 |
| IDEXX Laboratories (IDXX) | United States | $53.117B | 55.28 |
| Edwards Lifesciences (EW) | United States | $45.606B | 30.23 |
| Alcon (ALC) | Switzerland | $42.656B | 28.83 |
| IQVIA Holdings (IQV) | United States | $32.339B | 18.27 |
| DexCom (DXCM) | United States | $31.357B | 47.03 |
| Mettler-Toledo (MTD) | United States | $27.274B | 32.37 |
| STERIS (STE) | Ireland | $24.334B | 25.90 |
| Waters (WAT) | United States | $17.669B | 24.27 |
| SONOVA HOLDING (SONVY) | Switzerland | $16.740B | 0.00 |
| Hologic (HOLX) | United States | $15.342B | 16.62 |
| Penumbra (PEN) | United States | $10.038B | 73.33 |
| Sysmex ADR (SSMXY) | Japan | $8.699B | 27.64 |
| Globus Medical (GMED) | United States | $8.500B | 19.56 |
| Masimo (MASI) | United States | $8.473B | 28.51 |
| Teleflex (TFX) | United States | $5.432B | 8.77 |
| Glaukos (GKOS) | United States | $5.264B | 0.00 |
| TransMedics (TMDX) | United States | $4.501B | 68.42 |
| Integer Holdings (ITGR) | United States | $3.839B | 19.16 |
| LivaNova (LIVN) | United Kingdom | $2.897B | 16.58 |
| Veracyte (VCYT) | United States | $2.414B | 33.35 |
| Alphatec Holdings (ATEC) | United States | $2.338B | 0.00 |
| PROCEPT BioRobotics (PRCT) | United States | $2.247B | 0.00 |
| Artivion (AORT) | United States | $2.063B | 104.12 |
| Nihon Kohden (NHNKY) | Japan | $2.052B | 24.49 |
| Elekta AB (EKTAY) | Sweden | $1.874B | 16.84 |
| Pulse Biosciences (PLSE) | United States | $1.130B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $1.100B | 6.30 |
| OPKO Health (OPK) | United States | $1.072B | 0.00 |
| IRadimed (IRMD) | United States | $0.903B | 43.83 |
| Tandem Diabetes Care (TNDM) | United States | $0.752B | 0.00 |
| AxoGen (AXGN) | United States | $0.679B | 0.00 |
| SiBone (SIBN) | United States | $0.677B | 0.00 |
| Beta Bionics (BBNX) | United States | $0.656B | 0.00 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.552B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.527B | 4.23 |
| OrthoPediatrics (KIDS) | United States | $0.504B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.499B | 8.81 |
| Treace Medical Concepts (TMCI) | United States | $0.436B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.389B | 92.58 |
| Pacific Biosciences Of California (PACB) | United States | $0.384B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.381B | 9.69 |
| AngioDynamics (ANGO) | United States | $0.368B | 0.00 |
| RxSight (RXST) | United States | $0.340B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.339B | 0.00 |
| NeuroPace (NPCE) | United States | $0.308B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.290B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.289B | 19.92 |
| Neuronetics (STIM) | United States | $0.256B | 0.00 |
| 908 Devices (MASS) | United States | $0.253B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.226B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.223B | 0.00 |
| Inogen (INGN) | United States | $0.208B | 0.00 |
| CVRx (CVRX) | United States | $0.202B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.191B | 0.00 |
| Accuray (ARAY) | United States | $0.168B | 0.00 |
| LENSAR (LNSR) | United States | $0.152B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.146B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.144B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.138B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.128B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.106B | 0.00 |
| InspireMD (NSPR) | United States | $0.104B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.102B | 0.00 |
| Hyperfine (HYPR) | United States | $0.099B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.088B | 0.00 |
| QT Imaging Holdings (QTIH) | United States | $0.057B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.056B | 0.00 |
| Positron (POSC) | United States | $0.056B | 0.00 |
| Spectral AI (MDAI) | United States | $0.054B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.050B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.046B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.044B | 0.00 |
| Precision Optics (POCI) | United States | $0.036B | 0.00 |
| Envoy Medical (COCH) | United States | $0.032B | 0.00 |
| DarioHealth (DRIO) | United States | $0.020B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.020B | 0.00 |
| NexGel (NXGL) | United States | $0.019B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.018B | 0.00 | |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.017B | 0.00 |
| Tenon Medical (TNON) | United States | $0.013B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.008B | 0.00 |
| PAVmed (PAVM) | United States | $0.008B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.008B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.005B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.004B | 0.00 |
| Venus Concept (VERO) | Canada | $0.003B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.003B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.002B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.002B | 0.00 |
| Nuwellis (NUWE) | United States | $0.001B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.000B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $0.000B | 13.14 |